Worth Venture Partners’s Entera Bio ENTX Stock Holding History

Worth Venture Partners’s Portfolio ENTX Stock Details ENTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-16,454	Closed	-$39K	–	94
2019 Q3	$39K	Buy	16,454 +442	+3%	+$1.26K	0.02%	86
2019 Q2	$49K	Buy	16,012 +1,063	+7%	+$4.13K	0.03%	84
2019 Q1	$65K	Sell	14,949 -11,998	-45%	-$48.5K	0.04%	78
2018 Q4	$53K	Buy	26,947 +14,339	+114%	+$71.3K	0.04%	75
2018 Q3	$73K	Buy	+12,608	New	+$69.2K	0.05%	120

Other funds holding ENTX

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Worth Venture Partners's ENTX Position: Q4 2019 in Review

Worth Venture Partners sold out of Entera Bio (ENTX) in Q4 2019, closing a stake of 16,454 shares — an estimated $39K sold.

Worth Venture Partners first reported a position in ENTX in Q3 2018 and held it in 5 quarters. The position peaked at $73K in Q3 2018. 3 funds tracked by Wall St. Rank hold ENTX as of Q4 2019.

Worth Venture Partners reported no remaining Entera Bio position as of Q4 2019 after selling out during the quarter.
Worth Venture Partners sold 16,454 Entera Bio shares in Q4 2019, an estimated $39K.
Worth Venture Partners first reported a position in Entera Bio in Q3 2018 and held it in 5 quarters.
Worth Venture Partners's Entera Bio position peaked at $73K in Q3 2018.
3 funds tracked by Wall St. Rank held Entera Bio as of Q4 2019.

Based on Worth Venture Partners's 13F filing for Q4 2019, filed 14 Feb 2020.